MU
34
3
FAST
46
-3
KLAC
61
-2
NTRS
49
-5
ILMN
41
-3
DUK
64
2
PNC
57
-2
TRIP
66
5
XRX
52
-3
WAT
54
2
VMC
57
-3
THC
61
-3
QCOM
55
-4
AVB
65
-2
DOV
64
-5
AEE
61
3
O
31
3
GOOG
67
2
MCHP
43
-6
MDLZ
65
-2
MU
34
3
FAST
46
-3
KLAC
61
-2
NTRS
49
-5
ILMN
41
-3
DUK
64
2
PNC
57
-2
TRIP
66
5
XRX
52
-3
WAT
54
2
VMC
57
-3
THC
61
-3
QCOM
55
-4
AVB
65
-2
DOV
64
-5
AEE
61
3
O
31
3
GOOG
67
2
MCHP
43
-6
MDLZ
65
-2
Financhill
Back

Greystone Housing Impact Investors LP Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
50

GHI
Greystone Housing Impact Investors LP

Last Price:
13.58
Seasonality Move:
-4.71%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
50
Greystone Housing Impact Investors LP (GHI) is a Sell

Is Greystone Housing Impact Investors LP a Buy, Sell or Hold?

  • The current Greystone Housing Impact Investors LP [GHI] share price is $13.58. The Score for GHI is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • GHI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

GHI Stock Price Chart

What is Greystone Housing Impact Investors LP's stock price today?

  • The Greystone Housing Impact Investors LP share price today is $13.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GHI is experiencing slight selling pressure.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

GHI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 44.04 Sell
Chaikin Money Flow: -20468 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.48 - 14.06) Sell
Bollinger Bands (100): (13.96 - 15.24) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

GHI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.58 Buy
20-day SMA: 13.78 Sell
50-day SMA: 14.1 Sell
200-day SMA: 15.51 Sell
8-day EMA: 13.64 Sell
20-day EMA: 13.74 Sell
50-day EMA: 14.06 Sell
200-day EMA: 15.14 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Greystone Housing Impact Investors LP Earnings Growth & GHI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.18 per share, a decrease this year of $0.55 per share, and an increase next year of $0.44 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Greystone Housing Impact Investors LP Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):